Glucoraphanin, a natural broccoli compound sold as a dietary supplement to switch on the body's own protective enzymes, works only after gut bacteria or an added plant enzyme turn it into sulforaphane, its active form; conversion varies greatly between people. A few studies backed by one food company suggest small improvements in liver enzyme levels and, in older adults, mental processing speed. Side effects appear mild; long-term effects remain unmeasured. (Full Review)
| Marker | Target | Why |
|---|---|---|
| ALT | About 7–55 U/L | Expected to change: fell in glucoraphanin trials |
| GGT | About 8–61 U/L | Expected to change: trended lower |
| LDL cholesterol | No established target for glucoraphanin use; change from own baseline | Expected to change: fell with high-glucoraphanin broccoli |
| Fasting glucose | 70–99 mg/dL | Expected to change modestly in prediabetes |
| HbA1c | Not specified in the ER | Paired with fasting glucose every 6 months |
| TSH | 0.45–5.33 mIU/L | Safety check: a rise prompts a pause |
| Free thyroxine | Not specified in the ER | Paired with TSH if abnormal |
| Drug level (narrow-margin CYP1A2 or UGT1A1 drugs) | Not specified in the ER | Detects under-dosing from faster drug clearance |
Cadence: Baseline, then 12 weeks, then 24 weeks, then every 6–12 months while use continues; TSH repeated at 3 months in at-risk users